Pages that link to "Q36050571"
Jump to navigation
Jump to search
The following pages link to Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method (Q36050571):
Displaying 50 items.
- Dopamine and antipsychotic drug action revisited (Q22241697) (← links)
- The dopamine hypothesis of schizophrenia: version III--the final common pathway (Q22242827) (← links)
- An Evolutionary Framework to Understand Foraging, Wanting, and Desire: The Neuropsychology of the SEEKING System (Q22242984) (← links)
- Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor (Q24300744) (← links)
- Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia (Q24308818) (← links)
- GABAergic interneuron origin of schizophrenia pathophysiology. (Q24597790) (← links)
- Schizophrenia: more dopamine, more D2 receptors (Q24630726) (← links)
- Striatal dopamine in bulimia nervosa: a PET imaging study (Q24630782) (← links)
- Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder (Q24648385) (← links)
- Motor coordination deficits in mice lacking RGS9 (Q24648527) (← links)
- Animal models of schizophrenia: a critical review (Q24674909) (← links)
- Increased baseline occupancy of D2 receptors by dopamine in schizophrenia (Q24676113) (← links)
- Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia (Q24678573) (← links)
- Catecholamines and cognition after traumatic brain injury (Q26743582) (← links)
- Modeling psychiatric disorders for developing effective treatments (Q26784269) (← links)
- Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome (Q26824150) (← links)
- Application of cross-species PET imaging to assess neurotransmitter release in brain (Q26865012) (← links)
- An Overview of the Association between Schizotypy and Dopamine (Q26991569) (← links)
- The development, past achievements, and future directions of brain PET (Q27026331) (← links)
- Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population (Q27303919) (← links)
- Making Sense of: Sensitization in Schizophrenia (Q28077939) (← links)
- Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism (Q28084069) (← links)
- Jumping to conclusions in schizophrenia (Q28087488) (← links)
- NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development (Q28205016) (← links)
- The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia (Q28210979) (← links)
- A network of dopaminergic gene variations implicated as risk factors for schizophrenia (Q28259093) (← links)
- Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma? (Q28366409) (← links)
- Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates (Q28369835) (← links)
- Homozygous Deletion of Glutathione Peroxidase 1 and Aldehyde Dehydrogenase 1a1 Genes Is Not Associated with Schizophrenia-Like Behavior in Mice (Q28395280) (← links)
- Prenatal inflammation-induced hypoferremia alters dopamine function in the adult offspring in rat: relevance for schizophrenia (Q28474235) (← links)
- Amphetamine sensitization alters reward processing in the human striatum and amygdala. (Q28537648) (← links)
- Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex (Q28567004) (← links)
- Reversal of the expression pattern of Aldolase C mRNA in Purkinje cells and Ube 1x mRNA in Golgi cells by a dopamine D1 receptor agonist injections in the methamphetamine sensitized-rat cerebellum (Q28567966) (← links)
- Altered dopamine receptor and dopamine transporter binding and tyrosine hydroxylase mRNA expression following perinatal NMDA receptor blockade (Q28569752) (← links)
- Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice (Q28587873) (← links)
- Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction (Q28590145) (← links)
- Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring (Q28754716) (← links)
- Cerebral 5-HT release correlates with [(11)C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain (Q30303267) (← links)
- Developmental vitamin D deficiency and schizophrenia: the role of animal models. (Q30366744) (← links)
- Molecular substrates of schizophrenia: homeostatic signaling to connectivity (Q30383611) (← links)
- Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate (Q30403302) (← links)
- Chronic exposure of mutant DISC1 mice to lead produces sex-dependent abnormalities consistent with schizophrenia and related mental disorders: a gene-environment interaction study (Q30413272) (← links)
- Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia (Q30416848) (← links)
- Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid (Q30419650) (← links)
- Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging (Q30440091) (← links)
- Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. (Q30441885) (← links)
- Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia (Q30442031) (← links)
- Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion (Q30447828) (← links)
- GABA transporter-1 deficiency confers schizophrenia-like behavioral phenotypes (Q30451228) (← links)
- Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence (Q30453617) (← links)